Insiders / Doyle Janeen Noel

Doyle Janeen Noel

CIK 2069239personinsider

Companies

First seen

Jan 2, 2026

Last activity

Jan 2, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Janux Therapeutics, Inc. · JANX	Executive	80,000	126,000	2	—

2 positions · latest reported per filing

Company	Security	Shares	As of
Janux Therapeutics, Inc.	Common Stock	80,000	Jan 2, 2026
Janux Therapeutics, Inc.	Stock option (right to buy)Derivative	126,000	Jan 2, 2026

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 2, 2026	Grant	JANX Janux Therapeutics, Inc. Common Stock	$0	+36K +81.82%	80,000 0.13% of shares	low
Jan 2, 2026	Grant	JANX Janux Therapeutics, Inc. Stock option (right to buy)	—	+126K	126,000 0.21% of shares	low